Abstract
Using 6-hydroxy-3,4-dihydro-2(1H)-quinolone as the starting material, a series of 1-formamide-triazolo[4, 3-a]quinoline derivatives (6a-6n) was synthesized, the anticonvulsant effect and neurotoxicity of the compounds was calculated with maximal electroshock test and rotarod tests with intraperitoneally injected in KunMing mice. The results demonstrated that compound 7-(hexyloxy)-4,5-dihydro-[1,2,4] triazolo[4,3-a]quinoline-1-carboxamide (6d) was the most active one and also had the lowest toxicity. In the anti-maximal electroshock potency test, it showed median effective dose (ED50) of 30.1 mg/kg, median toxicity dose (TD50) of 286 mg/kg, and the protective index of 9.5 which is greater than the reference drug carbamazepine with the protective index value of 6.0.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Soud, Y. A., Al-Masoudi, N. A., and Ferwanah, Ael-R., Synthesis and properties of new substituted 1,2,4-triazoles: potential antitumor agents. Bioorg. Med. Chem., 11, 1701–1708 (2003).
Cui, L. J., Xie, Z. F., Piao, H. R., Li, G., Chai, K. Y., and Quan, Z. S., Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a] quinoline. Biol. Pharm. Bull., 28, 1216–1220 (2005).
Gasior, M., Carter, R. B., Goldberg, S. R., and Witkin, J. M., Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther., 282, 543–553 (1997).
Krall, R. J., Penry, J. K., White, B. G., Kupferberg, H. J., and Swinyard, E. A., Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia, 19, 409–428 (1978).
Leppik, I. E., Antiepileptic drugs in development: prospects for the near future. Epilepsia, 35, 29–40 (1994).
Lin, Z. and Kadaba, P. K., Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med. Res. Rev., 17, 537–572 (1997).
Perucca, E., The new generation of antiepileptic drugs: advantages and disadvantages. Br. J. Clin. Pharmacol., 42, 531–543 (1996).
Porter, R. J., Cereghino, J. J., Gladding, G. D., Hessie, B. J., Kupferberg, H. J., Scoville, B., and White, B. G., Antiepileptic Drug Development Program. Cleve. Clin. Q., 51, 293–305 (1984).
Quan, Z. S., Wang, J. M., Rae, J. R., Kwak, K. C., Kang, H. C., Jun, C. S., and Chai, K. Y., Synthesis of 6-Alkyloxyl-3,4-dihydro-2(1H)-quinoliones and Their Anticonvulsant Activities. Bull. Kor. Chem. Soc., 26, 1757–1760(2005).
Sun, X. Y., Jin, Y. Z., Li, F. N., Li, G., Chai, K. Y., and Quan, Z. S., Synthesis of 8-alkoxy-4,5-dihydro-[1,2,4]triazole [4,3-a]quinoline-1-ones and evaluation of their anticonvulsant properties. Arch. Pharm. Res., 29, 1080–1085 (2006).
Sun, X. Y., Zhang, L., Wei, C. X., Piao, H. R., and Quan, Z. S., Design, synthesis of 8-alkoxy-5,6-dihydro-[1,2,4]triazino [4,3-a]quinolin-1-ones with anticonvulsant activity. Eur. J. Med. Chem., 44, 1265–1270 (2009).
Wei, C. X., Li, F. N., Zhao, L. X., Zhao, L. M., and Quan, Z. S., Synthesis of 2-substituted-7-heptyloxy-4,5-dihydro-[1,2,4]-triazolo[4,3-a]quinolin-1(2H)-ones with anticonvulsant activity. Arch. Pharm. (Weinheim), 340, 491–495 (2007).
Xie, Z. F., Chai, K. Y., Piao, H. R., Kwak, K. C., and Quan, Z. S., Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines. Bioorg. Med. Chem. Lett., 15, 4803–4805 (2005).
Zimmer, H., Kokosa, J. M., and Shah, K. J., Synthsis of Condensed heterocyclic systems. VI. 1a Some ring closure reaxtions involving 1-hydrazinophthalazine. J. Org. Chem., 40, 2901–2906 (1975).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wei, CX., Deng, XQ., Chai, KY. et al. Synthesis and anticonvulsant activity of 1-formamide-triazolo[4,3-a]quinoline derivatives. Arch. Pharm. Res. 33, 655–662 (2010). https://doi.org/10.1007/s12272-010-0502-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0502-0